#11329 on the rich list of 14,644 insiders
Michael Geffner
Chief Medical Officer at Immunovant. Based in New York, New York.
$7.1M
in disclosed stock, −$159K (−2.20%) today
Live prices, last trade 3:57 PM ET
- Rank
- 11329th of 14,644
- Companies held
- 1
- Largest holding
- IMVT, 100.0% of total
- Latest SEC filing
- Oct 22, 2025
What the $7.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Immunovant IMVT Common Stock | Directly | 217,958 | $32.44 | $7.1M | 100.0% | Form 4, Oct 22, 2025 |
Share counts are the amounts Michael Geffner reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11326 | Gregory F. Holcombe Director, Orange County Bancorp. Middletown, NY | $7.1M |
| 11327 | Brian P. McAndrews Director, The New York Times. New York, NY | $7.1M |
| 11328 | Tao Fu President and CEO, Attovia Therapeutics. San Carlos, CA | $7.1M |
| 11329 | Michael Geffner Chief Medical Officer, Immunovant. New York, NY | $7.1M |
| 11330 | Michael J. Schlosser EVP and Chief Clinical Officer, HCA Healthcare. Nashville, TN | $7.1M |
| 11331 | Kathryn Romano Chief Accounting Officer, Krystal Biotech. Pittsburgh, PA | $7.1M |
| 11332 | Christopher J. Noyes SVP, CHIEF FINANCIAL OFFICER, Liberty Latin America. Denver, CO | $7.1M |
Other Immunovant insiders
All IMVT insiders- Peter Salzmann$38.2MChief Executive Officer. #3105 overall
- Frank Torti$32.7MDirector. #476 overall
- Julia G. Butchko$14.3MChief Development Officer. #6697 overall
- Eva Renee Barnett$12.9MChief Financial Officer. #7265 overall
- William L. Macias$11.6MChief Medical Officer. #7872 overall
- Mark S. Levine$10.4MChief Legal Officer. #8567 overall
Questions
How much stock does Michael Geffner own?
Michael Geffner holds $7,070,558 in listed stock based on SEC filings and current prices, mostly Immunovant (IMVT). That ranks 11329th on the Stock Rich List.
Is this Michael Geffner's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Michael Geffner last buy or sell stock?
The most recent open-market trade on file is a sale of 2,595 IMVT shares on Oct 22, 2025 at $19.03.